The Castrate Resistant Prostate Cancer Market is driven by rising prevalence of prostate cancer The castrate resistant prostate cancer market covers drugs that are used for the treatment of prostate cancer which has advanced to castrate resistant stage. Prostate cancer occurs when malignant cells form in the tissues of the prostate gland. In the initial stages, prostate cancer is often controlled with hormone therapy that lowers the levels of male sex hormones like testosterone. However,...
0 Shares
432 Views
0 Reviews